Cite

    Turner, M., Papadimitriou, A., Winkle, P., Segall, N., Levin, M., Doust, M., Johnson, C., Lucksinger, G., Fierro, C., Pickrell, P., Raanan, M., Tricou, V., Borkowski, A., & Wallace, D. (2020). immunogenicity and safety of lyophilized and liquid dengue tetravalent vaccine candidate formulations in healthy adults: a randomized, phase 2 clinical trial. Human vaccines & immunotherapeutics, 16(10), 2456–2464. http://access.bl.uk/ark:/81055/vdc_100113733742.0x00000a